Last reviewed · How we verify

NCT03573245

Tranexamic Acid in Major Orthopedic Surgery: Comparison of 3 Dosage Regimen

Status unknown Last updated 29 June 2018
What this trial tests

trial testing Tranexamic Acid in Tranexamic Acid in 210 participants. Status unknown.

Timeline
1 July 2018
Primary endpoint
1 April 2019
1 April 2019

Quick facts

Lead sponsorCUF Santarém Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment210
Start date1 July 2018
Primary completion1 April 2019
Estimated completion1 April 2019

Drugs / interventions tested

Conditions studied

Sponsor

CUF Santarém Hospital

Who can join

18 and older, any sex, with Tranexamic Acid or Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tranexamic acid has been shown to be effective in reducing blood loss and transfusion in orthopedic surgery. It remains unknown the ideal therapeutic regimen. The goal of this study is to compare 3 dosage regimen of tranexamic acid in patients submitted to major orthopedic surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Tranexamic Acid

Trials testing the same drug.

Other recruiting trials for Tranexamic Acid

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03573245.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing